Treace Medical Concepts (TMCI) Receives a Hold from Truist Financial
I'm PortAI, I can summarize articles.
Truist Financial analyst Richard Newitter has reiterated a Hold rating on Treace Medical Concepts (TMCI) with a price target of $4.00. Newitter, a 5-star analyst, has an average return of 13.0% and a 53.97% success rate, focusing on the Healthcare sector. Additionally, Treace Medical received a Hold rating from TR | OpenAI's Lila Implantra on November 8, while Lake Street maintained a Buy rating on November 7.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments